Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 137
Filter
Add more filters

Publication year range
1.
Clin Rheumatol ; 41(7): 2197-2203, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35099673

ABSTRACT

There is a gap in clinical knowledge regarding associations between specific inborn errors of immunity (IEIs) and rheumatologic diseases. This study reports the frequency of rheumatologic conditions in a large cohort of patients with IEI using the USIDNET (United States Immunodeficiency Network) registry. We used the USIDNET registry to conduct the analysis. We included all IEI patients within the registry for whom a diagnosed rheumatologic disease was reported. The total number of patients with IEI in our query was 5058. Among those, 278 (5.49%) patients had a diagnosis of rheumatologic disease. This cohort included 172 (61.8%) female and 106 (38.2%) male patients. Rheumatologic complications were highest in the interferonopathies (66.6%), autoimmune lymphoproliferative syndrome (ALPS) (13.7%), and immunoglobulin G subclass deficiency (IgGSD) (11.11%). Additionally, disease patterns were noted to be different in various IEI disease groups. Inflammatory myopathies were the most common rheumatologic condition in patients with X-linked agammaglobulinemia (1.65%), Sjogren's syndrome was the most common rheumatologic disease reported in ALPS patients (6.85%), and systemic lupus erythematosus was the most common rheumatologic disease in patients with chronic mucocutaneous candidiasis (CMC) (7.41%). Rheumatoid arthritis (RA) report rate was highest in patients with IgGSD (3.70%), specific antibody deficiency (SAD) (3.66%), and ALPS (2.74%). This study reports that rheumatologic diseases are frequently observed in patients with IEI. The frequency of different rheumatologic conditions was variable based on the underlying diagnosis. Clinicians caring for patients with IEI should be vigilant to monitor for rheumatologic complications. Key Points • The rates of reported rheumatologic diseases in the USIDNET registry are different in individual IEIs. • Further studies are needed to guide clinicians for detecting rheumatologic conditions earlier in patients with IEI.


Subject(s)
Agammaglobulinemia , Arthritis, Rheumatoid , Immunologic Deficiency Syndromes , Sjogren's Syndrome , Agammaglobulinemia/complications , Arthritis, Rheumatoid/complications , Female , Humans , Immunologic Deficiency Syndromes/complications , Immunologic Deficiency Syndromes/epidemiology , Male , Registries , Sjogren's Syndrome/complications , Sjogren's Syndrome/epidemiology
2.
Nat Med ; 7(1): 101-7, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11135623

ABSTRACT

The transcription factor early growth response protein 1 (EGR1) is overexpressed in a majority of human prostate cancers and is implicated in the regulation of several genes important for prostate tumor progression. Here we have assessed the effect of Egr1 deficiency on tumor development in two transgenic mouse models of prostate cancer (CR2-T-Ag and TRAMP). Using a combination of high-resolution magnetic resonance imaging and histopathological and survival analyses, we show that tumor progression was significantly impaired in Egr1-/- mice. Tumor initiation and tumor growth rate were not affected by the lack of Egr1; however, Egr1 deficiency significantly delayed the progression from prostatic intra-epithelial neoplasia to invasive carcinoma. These results indicate a unique role for Egr1 in regulating the transition from localized, carcinoma in situ to invasive carcinoma.


Subject(s)
DNA-Binding Proteins/physiology , Immediate-Early Proteins , Neoplasm Proteins , Prostatic Neoplasms/genetics , Transcription Factors/physiology , Animals , DNA-Binding Proteins/genetics , Early Growth Response Protein 1 , Gene Expression Regulation, Neoplastic , Male , Mice , Mice, Transgenic , Precancerous Conditions/pathology , Repressor Proteins/physiology , Transcription Factors/genetics
3.
Am J Med Genet A ; 152A(6): 1510-4, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20503327

ABSTRACT

Cerebral, ocular, dental, auricular, skeletal syndrome (CODAS, OMIM 600373) is a very rare congenital malformation syndrome. This clinical entity is highly distinctive and associates mental retardation, cataract, enamel abnormalities, malformations of the helix, epiphyseal and vertebral malformations, and characteristic dysmorphic features. Since 1991, only three affected children have been reported. The etiology and pattern of inheritance of CODAS syndrome still remain unknown. We describe a new sporadic case presenting with all the characteristic features of CODAS syndrome associated with previously unreported malformations of the heart, larynx, and liver. All investigations such as karyotype, metabolic screening and array CGH were normal.


Subject(s)
Abnormalities, Multiple/diagnosis , Bone and Bones/abnormalities , Cataract/diagnosis , Cerebral Cortex/abnormalities , Heart Atria/abnormalities , Intellectual Disability/diagnosis , Muscle, Skeletal/abnormalities , Tooth Abnormalities/diagnosis , Abnormalities, Multiple/genetics , Cataract/congenital , Cataract/genetics , Child, Preschool , Humans , Intellectual Disability/genetics , Male , Syndrome , Tooth Abnormalities/genetics
4.
J Otolaryngol Head Neck Surg ; 49(1): 32, 2020 May 29.
Article in English | MEDLINE | ID: mdl-32471510

ABSTRACT

BACKGROUND: First branchial cleft anomalies are rare, accounting for only 10% of all branchial cleft anomalies. We report an even more rare and unique case of a branchial cleft cyst with features of both first and second arch derivatives. CASE PRESENTATION: A 6-year-old boy presented to us with a left conductive hearing loss associated with pre-tympanic keratin debris and an ipsilateral painful cervical mass. He had a past medical history of left ear surgery for presumed cholesteatoma 2 years prior and left neck abscess drainage 6 months prior. CT and MRI revealed a lesion originating in the external auditory canal and extending cervically through a bony canal located medial to the facial nerve and terminating as a parapharyngeal cyst. The complete removal was accomplished in one surgical stage consisting of three distinct steps: robotic assisted transoral resection of the pharyngeal cyst, an endaural approach and a parotidectomy approach. CONCLUSION: We believe that our detailed description of this rare first branchial cleft cyst with pharyngeal extension, possibly a hybrid case between a first and second branchial cyst, can serve as a valuable tool to Otolaryngologists - Head and Neck Surgeons who come across a similar unusual presentations.


Subject(s)
Branchioma/complications , Cysts/complications , Ear Canal/abnormalities , Pharyngeal Diseases/complications , Branchioma/diagnostic imaging , Branchioma/surgery , Child , Cholesteatoma, Middle Ear/surgery , Cysts/surgery , Facial Nerve , Hearing Loss, Conductive/etiology , Humans , Magnetic Resonance Imaging , Male , Parapharyngeal Space , Pharyngeal Diseases/surgery , Pharynx/surgery , Robotic Surgical Procedures , Tomography, X-Ray Computed
5.
Int J Pediatr Otorhinolaryngol ; 72(2): 279-83, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18082899

ABSTRACT

Granular cell tumors (GCT), also known as Abrikossoff tumors, are rare tumors found largely in children, with few reports of laryngo-tracheal involvement. Two childhood cases of laryngo-tracheal GCT are reported here, of which one case had multifocal lesions. The histopathological features and the therapeutic management of GCT are also discussed.


Subject(s)
Granular Cell Tumor/diagnosis , Laryngeal Neoplasms/diagnosis , Tracheal Neoplasms/diagnosis , Airway Obstruction/etiology , Airway Obstruction/surgery , Child , Dyspnea/etiology , Dyspnea/surgery , Female , Granular Cell Tumor/surgery , Hoarseness/etiology , Hoarseness/surgery , Humans , Laryngeal Neoplasms/surgery , Laryngoscopy , Laser Therapy , Male , Tracheal Neoplasms/surgery , Voice Disorders/etiology , Voice Disorders/surgery
6.
Arch Pediatr ; 15(4): 473-6, 2008 Apr.
Article in French | MEDLINE | ID: mdl-18314315

ABSTRACT

Congenital cervical cysts, sinuses and fistulae are uncommon malformations. Diagnosis and management of congenital cervical cysts, sinuses and fistulae requires a good understanding of their embryological development and topography. Thyroglossal duct cysts are most common, followed by branchial cleft anomalies and dermoid cysts. In this review, we discuss both the classical and current aspects of these malformations.


Subject(s)
Cysts/congenital , Fistula/congenital , Head , Neck , Paranasal Sinus Diseases/congenital , Female , Humans , Infant, Newborn , Male
7.
Eur Ann Otorhinolaryngol Head Neck Dis ; 135(2): 91-94, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29054752

ABSTRACT

OBJECTIVES: To study recent cases of esophageal injury due to button-battery ingestion in children presenting in pediatric ENT emergency departments of the Paris area of France (Île-de-France region), in order to propose appropriate preventive measures. MATERIAL AND METHOD: A retrospective descriptive single-center study included all children under 15 years of age, presenting in pediatric ENT emergency departments between January 2008 and April 2014 for button-battery ingestion with esophageal impaction requiring emergency removal. RESULTS: Twenty-two boys and 4 girls, with a median age of 25 months, were included. Twenty-five of the 26 batteries had diameters of 20mm or more. Median esophageal impaction time was 7 hours 30 minutes (range, 2 to 72 hours). The complications rate was 23%. Mean hospital stay cost was €38,751 (range, €5130-119,737). The origin of the battery was known in 23 of the 26 cases: remote control without screw-secured compartment (42.3%), open battery pack (15.4%), children's toy (15.3%), camera (7.7%), watch (1 case) and hearing aid without screw-secured compartment (1 case). CONCLUSION: Esophageal lesions due to ingestion of button-batteries in children are almost always due to batteries larger than 20mm in diameter, mostly from devices with a poorly protected compartment, or batteries that are not individually packaged. These lesions cause serious complications in a quarter of cases and their management entails high health costs. Legislation requiring screw-secured compartments and individual blisters for batteries could have prevented 69.2% of the ingestions.


Subject(s)
Eating , Electric Power Supplies/adverse effects , Emergencies/epidemiology , Esophagus/injuries , Foreign Bodies/therapy , Adolescent , Child , Child, Preschool , Emergencies/economics , Emergency Service, Hospital , Esophagus/surgery , Female , Foreign Bodies/complications , Foreign Bodies/economics , Foreign Bodies/epidemiology , France/epidemiology , Hospitals, Pediatric , Humans , Infant , Length of Stay , Male , Paris , Retrospective Studies , Risk Factors
8.
Int J Pediatr Otorhinolaryngol ; 70(4): 689-96, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16226319

ABSTRACT

OBJECTIVE: The purpose of the study is to present the results of cochlear implantation in case of deafness involving mutations in the OTOF gene. This form of deafness is characterized by the presence of transient evoked otoacoustic emissions (TEOAE). In cases of profound deafness with preserved TEOAE, two main etiologies should be considered: either an auditory neuropathy (a retrocochlear lesion) or an endocochlear lesion. It is essential to differentiate these two entities with regards to therapy and screening. PATIENTS: We report two children who presented with profound prelingual deafness, confirmed by the absence of detectable responses to auditory evoked potentials (AEP), associated with the presence of bilateral TEOAE. Genetic testing revealed mutations in OTOF, confirming DFNB9 deafness. Both patients have been successfully implanted (with a follow-up of 18 and 36 months, respectively). MAIN OUTCOME MEASURES: Clinical (oral production, closed and open-set words and sentences list, meaningful auditory integration scale), audiometric evaluation (TEOAE, AEP) before and after implantation, and neural response telemetry (NRT). RESULTS: Both patients present a good quality of clinical responses and electrophysiological tests after implantation, indicating satisfactory functioning of the auditory nerve. This confirms the endocochlear origin of DFNB9 and suggests that these mutations in OTOF lead to functional alteration of inner hair cells. CONCLUSION: In the absence of a context of neurological syndrome, the combination of absent AEP and positive TEOAE should lead to a genetic screening for mutations in OTOF, in order to undertake the appropriate management.


Subject(s)
Cochlear Implantation , DNA/analysis , Evoked Potentials, Auditory, Brain Stem/physiology , Hearing Loss, Sensorineural/genetics , Hearing Loss, Sensorineural/surgery , Membrane Proteins/genetics , Mutation , Otoacoustic Emissions, Spontaneous , Audiometry , Child, Preschool , DNA Mutational Analysis , Female , Hearing Loss, Sensorineural/congenital , Humans , Infant , Phenotype
9.
Ann Otolaryngol Chir Cervicofac ; 123(6): 325-32, 2006 Dec.
Article in French | MEDLINE | ID: mdl-17202991

ABSTRACT

OBJECTIVES: Slide Tracheoplasty has progressively become the gold standard in the management of long-segment tracheal stenosis in children and infants. However, in certain situations this operation might become difficult and others techniques might be preferred. MATERIAL AND METHODS: Five patients, 1 to 6 month old had surgery by our team, for complex tracheal stenosis between 2001 and 2005. Tracheal hypoplasia was considered complex because it was associated to either: an acquired critical stenosis, a cricoid stenosis, a bronchial stenosis, a tracheal bronchus or associated to oesophageal atresia and severe tracheomalacia. All of them have been treated by a modified slide tracheoplasty. RESULTS: The postoperative status required an average of 15 days in ICU, including 8 days of ventilation. Two patients had laryngeal nerve injury. Medium term follow up (27 months) demonstrated no need for re-intervention, good potential growth and normal child activity. CONCLUSIONS: Slide tracheoplasty can provide good results in certain cases of severe and complex tracheal hypoplasia in infants.


Subject(s)
Trachea/surgery , Tracheal Stenosis/congenital , Tracheal Stenosis/surgery , Age Factors , Female , Follow-Up Studies , Humans , Infant , Intensive Care Units , Length of Stay , Male , Respiration, Artificial , Time Factors , Treatment Outcome
10.
Article in English | MEDLINE | ID: mdl-26520479

ABSTRACT

OBJECTIVES: We report results for newborn hearing screening in a cohort of children born in the Île-de-France region of France, as part of a national screening program set up by the French national health insurance agency. MATERIALS AND METHODS: A prospective study was performed on neonates undergoing hearing screening by automated auditory brainstem response at 35 dB in maternity departments between 2005 and 2011. In case of positive findings, a further check was performed; if this was also positive in one or both ears, the child was referred to the diagnostic center. RESULTS: The study recruited 27,885 births; 96% of neonates were tested. Retest was positive in 0.84% of cases. Bilateral hearing loss was diagnosed in 0.63% of infants. Fifty-nine percent of these had ≥ 1 risk factor. Hearing normalized by end of follow-up in 25% of cases. Hearing loss was moderate in 59% of hearing-impaired children, severe in 12% and profound in 29%. Mean age at hearing aid fitting ranged from 4 months in profound hearing loss to 11.4 months in moderate hearing loss. In children receiving a cochlear implant, mean age at implantation was 14 months. CONCLUSION: Newborn hearing screening is now public policy. It is effective in terms of exhaustiveness, age at diagnosis and early management. Caution is appropriate in the treatment of moderate hearing loss. In case of moderate hearing loss associated with otitis media serosa, transtympanic aerators should be suggested as of the age of 6 months to enable hearing threshold measurement. Hearing aid fitting can then be considered around 9 months of age if hearing has not improved.


Subject(s)
Hearing Loss, Bilateral/diagnosis , Neonatal Screening , France , Hearing Loss, Bilateral/epidemiology , Hearing Loss, Bilateral/therapy , Hearing Tests , Humans , Infant, Newborn , Prevalence , Prospective Studies
11.
Article in English | MEDLINE | ID: mdl-26493114

ABSTRACT

INTRODUCTION: Rhabdomyosarcoma (RMS) is the most frequent soft-tissue sarcoma in children and makes up 5% of all pediatric malignant tumors. The main head and neck locations are the base of the skull, nasopharynx, nasal cavity and orbit. An outer ear location is considered extremely rare. We present 3 cases of children, aged 6 to 14 years, presenting with auricular RMS. CASE REPORTS: The first child, aged 6, was managed by 4 chemotherapy cycles followed by surgical resection of the tumor bed, completed by 5 further cycles of chemotherapy. The second, aged 14, was managed by 4 chemotherapy cycles followed by external radiation therapy of the tumor bed and lymph node areas, completed by 5 further cycles of chemotherapy. The third, aged 13, was managed by 4 chemotherapy cycles followed by surgery, completed by 5 further cycles of chemotherapy. DISCUSSION: In these 3 patients, the treatment program achieved complete disease control. Prognosis was good, thanks to good surgical access. Diagnosis should be considered in case of unusual progressive swelling in the outer ear.


Subject(s)
Ear Neoplasms/pathology , Ear, External/pathology , Rhabdomyosarcoma/pathology , Adolescent , Chemotherapy, Adjuvant , Child , Ear Neoplasms/therapy , Ear, External/surgery , Female , Humans , Male , Radiotherapy, Adjuvant , Remission Induction , Retrospective Studies , Rhabdomyosarcoma/therapy
12.
Otol Neurotol ; 26(4): 668-73, 2005 Jul.
Article in English | MEDLINE | ID: mdl-16015165

ABSTRACT

OBJECTIVE: To evaluate surgical aspects and results of cochlear implantation in inner ear malformations. STUDY DESIGN: Retrospective cohort study. SETTING: Ear, nose, and throat department of a tertiary referral hospital. PATIENTS: Out of 260 implanted children, 18 (6.9%) had inner ear malformations: complex cochleovestibular malformation (n = 11), common cavity (n = 1), and enlarged vestibular aqueduct (EVA) (n = 6). Deafness was progressive in 12 cases (G1) and congenital in 6 cases (G2). Genetics lead to diagnosis in 12 of 13 cases: PSD mutation (n = 11), Waardenburg syndrome (n = 1), negative (1). Mean age at implant was 7.8 years. Mean follow-up period was 48 months. MAIN OUTCOME MEASURES: Medical and surgical outcomes were reported. Closed (CSW) and open (OSW) set word perception and level of speech production were evaluated each year. The results were compared pre- and postoperatively and between the two groups. RESULTS: Gusher at surgery was observed in 50% of cases, with a persistent leak in one case. No facial injury or infectious complications were observed. At 12 months, 83% of the population had achieved more than 75% recognition in CSW, versus 16% before implant (p = 0.001). After 2 years, 64% of patients had more than 50% recognition in OSW. Good oral language was seen in 76% at 2 years and 100% at 3 years, versus 55% before implant (respectively, p > 0.05 and p = 0.03). At 1 year after implant, 83% of the G1 and 20% of the G2 achieved more than 50% recognition in OSW (p = 0.02). After 24 months, 83% of G1 and 40% of G2 had more than 50% in OSW (p > 0.05). Before implant, 75% in G1 and 0% in G2 had good oral language (p = 0.01). At 1 year, 83% in G1 and 16% in G2 had good oral language (p = 0.02). At 2 years, 100% in G1 and 20% in G2 had good oral language (p = 0.02). One child in G1 had no improvement after implantation. CONCLUSIONS: No major complication was seen. Perceptive and linguistic results were variable and depended on the type of the deafness. In progressive deafness, the perceptive and linguistic result are expected to be good. In congenital deafness, the results are more variable.


Subject(s)
Cochlear Implantation , Deafness/surgery , Ear, Inner/abnormalities , Adolescent , Adult , Child , Child, Preschool , Cohort Studies , Deafness/congenital , Deafness/physiopathology , Disease Progression , Humans , Retrospective Studies , Speech Perception , Speech Production Measurement , Treatment Outcome
13.
Otol Neurotol ; 26(4): 748-54, 2005 Jul.
Article in English | MEDLINE | ID: mdl-16015179

ABSTRACT

AIMS: The purpose of the study was to define boundaries between endocochlear hearing loss and auditory neuropathy in children with congenital profound hearing loss and positive otoacoustic emissions. PATIENT: A child presented with bilateral profound hearing loss, which was confirmed by the absence of evoked auditory potentials at 110 dB and with conserved otoacoustic emissions. The lack of any relevant medical history, a normal neurologic pediatric examination, and the improvement obtained with powerful hearing aids suggested an endocochlear cause. Genetic testing identified mutations in OTOF, responsible for the DFNB9 recessive form of hearing loss. RESULTS: In recent years, cases of children with hearing loss associated with positive otoacoustic emissions have been labeled as "auditory neuropathy." Classically, this form of hearing loss is refractory to the use of hearing aids and cochlear implants. Mutations in OTOF lead to inner hair cells dysfunction, whereas the outer hair cells are initially functionally preserved. As this form of endocochlear hearing loss can be detected at a molecular level, genetic testing can be proposed for cases of nonsyndromic auditory neuropathy, as those children could benefit from cochlear implantation. CONCLUSION: It is advisable to reserve the term "auditory neuropathy" for patients who present hearing loss and conserved otoacoustic emissions in the context of a neurologic syndrome or for children with suggestive perinatal history. In other cases, genetic testing for mutations in OTOF should be carried out.


Subject(s)
Cochlear Diseases/complications , Hearing Loss, Sensorineural/diagnosis , Hearing Loss, Sensorineural/physiopathology , Hearing Loss/diagnosis , Hearing Loss/etiology , Otoacoustic Emissions, Spontaneous , Child, Preschool , Diagnosis, Differential , Genetic Testing , Hearing Loss/genetics , Hearing Loss, Sensorineural/congenital , Humans , Membrane Proteins/genetics , Mutation
14.
Eur Ann Otorhinolaryngol Head Neck Dis ; 132(6): 317-20, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26363600

ABSTRACT

OBJECTIVE: To analyze speech in children with profound hearing loss following congenital cytomegalovirus (cCMV) infection with cochlear implantation (CI) before the age of 3 years. MATERIAL AND METHODS: In a cohort of 15 children with profound hearing loss, speech perception, production and intelligibility were assessed before and 3 years after CI; variables impacting results were explored. RESULTS: Post-CI, median word recognition was 74% on closed-list and 48% on open-list testing; 80% of children acquired speech production; and 60% were intelligible for all listeners or listeners attentive to lip-reading and/or aware of the child's hearing loss. Univariate analysis identified 3 variables (mean post-CI hearing threshold, bilateral vestibular areflexia, and brain abnormality on MRI) with significant negative impact on the development of speech perception, production and intelligibility. CONCLUSION: CI showed positive impact on hearing and speech in children with post-cCMV profound hearing loss. Our study demonstrated the key role of maximizing post-CI hearing gain. A few children had insufficient progress, especially in case of bilateral vestibular areflexia and/or brain abnormality on MRI. This led us to suggest that balance rehabilitation and speech therapy should be intensified in such cases.


Subject(s)
Cochlear Implantation , Cytomegalovirus Infections/complications , Hearing Loss/surgery , Hearing Loss/virology , Speech Intelligibility , Speech Perception , Child, Preschool , Early Medical Intervention , Female , Hearing Loss/physiopathology , Humans , Infant , Language , Male , Retrospective Studies , Speech Production Measurement
15.
Int J Pediatr Otorhinolaryngol ; 79(8): 1268-74, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26071017

ABSTRACT

OBJECTIVE: To compare the residual cholesteatoma detection accuracy of diffusion-weighted (DW) and T1 delayed sequences for magnetic resonance at one year postoperative with second-look surgery in pediatric patients who have undergone primary middle ear surgery for cholesteatoma. METHODS: This was a prospective monocentric consecutive study conducted in a tertiary academic referral center. Children were referred for MR imaging (MRI) one year after surgery. A 1.5T MRI was utilized, using nonecho-planar DW images and delayed gadolinium-enhanced T1-weighted images. Accuracy of magnetic resonance imaging was assessed by two radiologists before surgery. Interobserver and intraobserver agreements were assessed using the κ test. Magnetic resonance imaging data were compared with surgery, which was considered as the gold standard. RESULTS: Twenty-four consecutive unselected pediatric patients were included. Sensitivity, specificity, positive predictive value, and negative predictive value for the first observer were of 40%, 86%, 67%, and 67%, respectively, and those for the second observer were 30%, 86%, 60%, and 63%, respectively. The only two cholesteatoma with a size superior to 3mm were diagnosed before surgery, but the majority of small cholesteatoma were not detected. CONCLUSIONS: MRI is a key examen to diagnosed the residual cholesteatoma but is limited by the size of the lesion under 3mm. Delaying the realization of MRI during follow-up could increase sensitivity, thus avoiding misdiagnosis as well as unnecessary second look surgery.


Subject(s)
Cholesteatoma, Middle Ear/diagnosis , Cholesteatoma, Middle Ear/surgery , Diffusion Magnetic Resonance Imaging , Second-Look Surgery , Adolescent , Child , Child, Preschool , Cholesteatoma, Middle Ear/pathology , Contrast Media , Ear, Middle/pathology , Female , Follow-Up Studies , Gadolinium , Humans , Male , Neoplasm, Residual , Observer Variation , Predictive Value of Tests , Prospective Studies
16.
Pediatr Infect Dis J ; 17(7): 631-8, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9686731

ABSTRACT

OBJECTIVES: To assess the clinical outcome and risk of failure after oral vs. intravenous treatment in otitis media caused by penicillin-resistant pneumococci. To determine the possible correlations between pneumococcal minimal inhibitory concentration (MIC) to penicillin and clinical outcome. DESIGN: Retrospective study of 156 cases collected between 1993 and 1995. Mean follow-up: 5 months. Setting. Two tertiary academic medical centers in Paris, France. PATIENTS AND METHODS: Pneumococcus was isolated from 191 of 570 ear samples obtained from children with otitis media and shown to be penicillin-resistant in 156. Medical history, antibiotic therapy during the previous 3 months and day-care center attendance were reviewed. For the current episode microbiologic characteristics of the isolated strains, type of treatment, therapy efficacy and clinical outcome were analyzed. Patients were predominantly young (76.3% were <1 year old) and bacteriologic samples were taken mainly because of previous treatment failure. RESULTS: Among 156 children with pneumococcal penicillin-resistant otitis media, 72.2% attended day-care centers, 71.8% had been previously treated with aminopenicillin and 52.5% with cephalosporins. Failure of previous empirical oral therapy was noted in 84% (one-third of these had been receiving amoxicillin-clavulanate). Patients treated intravenously had had a more protracted otitis but no greater number of previous episodes of acute otitis media than those receiving oral therapy. Acute mastoiditis occurred in 4 infants resulting in mastoidectomy. Oral treatment (mainly with high dose amoxicillin,120 to 150 mg/kg/day) and intravenous therapy (cephalosporin or glycopeptide) had been used in 59 and 41%, respectively. Mean duration of therapy was 10.7 days. Three failures (1.9%) and 10 recurrences (6.4%, average 28 days) occurred. No statistical difference was found between intravenous and oral therapy with respect to risk of recurrence. A high penicillin MIC value was correlated with previous antibiotic treatment but not with clinical outcome. CONCLUSIONS: Oral therapy appears to be as effective as intravenous therapy for the treatment of penicillin-resistant pneumococcal otitis media. Intravenous treatment should not necessarily be dictated by the penicillin susceptibility value but should be considered in cases of failure to thrive, persistent otitis or other complications.


Subject(s)
Otitis Media/drug therapy , Otitis Media/microbiology , Penicillin Resistance , Pneumococcal Infections/drug therapy , Streptococcus pneumoniae/drug effects , Acute Disease , Administration, Oral , Amoxicillin/administration & dosage , Amoxicillin/pharmacology , Cefotaxime/administration & dosage , Cefotaxime/pharmacology , Ceftriaxone/administration & dosage , Ceftriaxone/pharmacology , Cephalosporins/administration & dosage , Cephalosporins/pharmacology , Humans , Infant , Injections, Intravenous , Microbial Sensitivity Tests , Penicillins/administration & dosage , Penicillins/pharmacology , Retrospective Studies , Streptococcus pneumoniae/isolation & purification , Treatment Failure
17.
Pediatr Pulmonol ; Suppl 23: 10-2, 2001.
Article in English | MEDLINE | ID: mdl-11886103

ABSTRACT

Abnormalities of tracheal rigidity, which may lead to the collapse of the airway during expiration and consequent complications, characterize two groups of disorders: tracheomalacia (weakness of the anterior cartilaginous arc of the trachea) and tracheal dyskinesia (dysfunction of the posterior membranous trachea). Tracheal dyskinesia can either be isolated or associated with a more complex syndrome of malformations: esophageal atresia, tracheoesophageal fistula and laryngotracheal cleft. Although our knowledge of the embryological development of the tracheoesophageal axis remains limited, the existence of these associations suggests that tracheal dyskinesia is of congenital origin. The presentation of three clinical cases demonstrates that the coexistence of a midline malformation and of tracheal dyskinesia complicates the therapeutic management of the first malformation. In particular, the postoperative follow-up is often more difficult, and a long-term tracheostomy is often required (sometimes for several years). However, it must be pointed out that tracheal dyskinesia, even in the associated forms, has a good long-term prognosis, since spontaneous resolution as the child grows up is the rule.


Subject(s)
Dyskinesias/embryology , Dyskinesias/etiology , Esophagus/abnormalities , Esophagus/embryology , Larynx/abnormalities , Larynx/embryology , Trachea/abnormalities , Trachea/embryology , Tracheal Diseases/embryology , Tracheal Diseases/etiology , Child, Preschool , Dyskinesias/surgery , Esophagus/surgery , Humans , Infant , Infant, Newborn , Larynx/surgery , Trachea/surgery , Tracheal Diseases/surgery , Tracheostomy , Treatment Outcome
18.
Laryngoscope ; 107(6): 795-800, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9185736

ABSTRACT

Thirty-six children with nasal dermoid sinus cysts were treated in the Department Pediatric Otolaryngology, Armand Trousseau's Children's Hospital (Paris, France) between 1974 and 1994. Ten of the patients presented with a midline cyst only, eight had nasal pits only, and 18 had combined cases. In six of the 36 patients, presurgical imagery indicated signs of intracranial extension of the tract, reaching the foramen caecum without intracranial mass. Three surgical techniques were used: an external rhinoplasty approach with medial crura section in 23 cases, a direct median approach in seven cases, and a paracanthal approach in six cases. Only two cases had meningeal adherences. Two superficial recurrences occurred within the 7-year follow-up period. Widening of the scar occurred in four children after verticomedian approach or nasal pit excision. The external rhinoplasty procedure with medial crura section results in a wide surgical approach, low recurrence rate, and good aesthetic results.


Subject(s)
Dermoid Cyst/surgery , Nose Neoplasms/surgery , Adolescent , Adult , Child , Child, Preschool , Dermoid Cyst/diagnosis , Female , Humans , Infant , Magnetic Resonance Imaging , Male , Neoplasm Recurrence, Local , Nose Neoplasms/diagnosis , Retrospective Studies , Rhinoplasty/methods , Tomography, X-Ray Computed
19.
Laryngoscope ; 105(10): 1111-7, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7564844

ABSTRACT

Between 1987 and 1993, 115 children were operated on for severe forms of laryngomalacia in two pediatric ear, nose, and throat (ENT) departments. The criteria used to determine the severity of the illness were selected following short hospitalization periods during which the children received both pediatric and ENT checkups. Based on clinical manifestations and/or the results of pH monitoring gastroesophageal reflux was found to be present in 68% of the children in the study. Detailed analysis and endoscopy were used to differentiate the symptoms that were related to laryngomalacia from those that were caused by other conditions, including mixed-breathing, swallowing, and sucking difficulties. Endoscopic resection of the aryepiglottic folds, with or without the use of a carbon dioxide laser, resulted in rapid improvement of both ventilation and swallowing. The success rate of this simple and effective procedure, which has no inherent morbidity, was 98% in an average follow-up period of 30 months. Only seven children required an additional similar procedure. The procedure failed in only two children, who needed to be tracheotomized. Given these excellent results, endoscopic resection can be considered an effective technique for the management of severe laryngomalacia.


Subject(s)
Laryngeal Diseases/surgery , Larynx/abnormalities , Larynx/surgery , Acute Disease , Child, Preschool , Combined Modality Therapy , Endoscopy/methods , Female , France , Humans , Infant , Infant, Newborn , Laryngeal Diseases/congenital , Laryngeal Diseases/diagnosis , Laryngoscopy , Male , Postoperative Care , Reoperation , Respiratory Sounds , Retrospective Studies
20.
Laryngoscope ; 100(11): 1225-8, 1990 Nov.
Article in English | MEDLINE | ID: mdl-2233088

ABSTRACT

Fourteen children aged between 6 months and 7 years (mean age = 3.5 years) were treated by CO2 broncholaser in the ENT Department of Trousseau Hospital. Three groups of diagnostic indication were identified: 1. Granulomas treated after mucosal trauma (tracheotomy, foreign body). 2. Granulomas due to pulmonary and/or lymph node tuberculosis. 3. Adhesions and stenosis secondary to neonatal ventilation. The operative and anesthetic technique is described in detail, together with any possible adverse events. The CO2 broncholaser appears to be a technique of choice in this age group, in which the narrowness of the airways makes any endoscopic procedure difficult. The broncholaser allows the early treatment of obstructive tracheobronchial pathology with its risks of severe ventilatory sequelae.


Subject(s)
Bronchi/surgery , Laser Therapy , Trachea/surgery , Child , Child, Preschool , Female , Humans , Infant , Laser Therapy/instrumentation , Laser Therapy/methods , Male , Postoperative Complications
SELECTION OF CITATIONS
SEARCH DETAIL